Pancreatic Cancer Gene Identified
Tuesday, January 3, 2012
According to information printed in Cancer Discovery, the most recent journal of the yankee Association for Cancer analysis, the chance of inheriting pancreatic cancer is also increased by mutations within the ATM gene.
Less than five-hitter of diagnosed pancreatic cancer victims survive beyond five years, that makes pancreatic cancer one in all the foremost deadly cancers, and regarding 100 percent of pancreatic cancer victims stem from families with multiple cases of this cancer.
Lead researcher Alison Klein, Ph.D., associate professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and director of the National Familial Pancreas Tumor Registry stated:
"There was important reason to believe this clustering was owing to genetics, however we have a tendency to had not, to the current purpose, been able to notice the causative genes that explained the cluster of pancreatic cancer for a majority of those families."
Klein and her team performed next-generation sequencing with whole genome and whole exome analyses and detected ATM gene mutations in 2 connected people inside an equivalent family who had an equivalent pancreatic cancer.
Initial findings of assessing an outsized patient cohort revealed ATM mutations in four of 166 patients with pancreatic cancer, however were absent in a hundred ninety spousal management subsets.
Klein says that knowing the presence of the ATM gene could lead on to improved pancreatic cancer screening, provided that pancreatic cancer is that the fourth most typical explanation for cancer-related mortality.
At present, no counseled screening tests exist for pancreatic cancer, though several doctors perform an endoscopy as a screening tool, this screening approach remains being evaluated in clinical trials.
Less than five-hitter of diagnosed pancreatic cancer victims survive beyond five years, that makes pancreatic cancer one in all the foremost deadly cancers, and regarding 100 percent of pancreatic cancer victims stem from families with multiple cases of this cancer.
Lead researcher Alison Klein, Ph.D., associate professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and director of the National Familial Pancreas Tumor Registry stated:
"There was important reason to believe this clustering was owing to genetics, however we have a tendency to had not, to the current purpose, been able to notice the causative genes that explained the cluster of pancreatic cancer for a majority of those families."
Klein and her team performed next-generation sequencing with whole genome and whole exome analyses and detected ATM gene mutations in 2 connected people inside an equivalent family who had an equivalent pancreatic cancer.
Initial findings of assessing an outsized patient cohort revealed ATM mutations in four of 166 patients with pancreatic cancer, however were absent in a hundred ninety spousal management subsets.
Klein says that knowing the presence of the ATM gene could lead on to improved pancreatic cancer screening, provided that pancreatic cancer is that the fourth most typical explanation for cancer-related mortality.
At present, no counseled screening tests exist for pancreatic cancer, though several doctors perform an endoscopy as a screening tool, this screening approach remains being evaluated in clinical trials.
0 comments:
Post a Comment